01 /NAM strategy & adoption
Understand what your evidence supports.
Clarify the intended use, assess the evidence and identify the next steps for partnering, adoption or an institutional programme.
Explore NAM servicesScience and strategy for human-relevant biomedicine
Evidence, strategy and delivery for your next biomedical milestone.
We help biomedical companies, research organisations and public institutions assess NAM evidence, develop AI and data tools, and plan and deliver projects.
Start with the work you need done. Scope, responsibilities, timing and fee are agreed before delivery.
Three ways to work with FRESCI
Choose your task. Start with a defined scope.02 /Biomedical AI & data
Build a tool around a scientific task.
Commission a knowledge tool, or assess and test an AI workflow with scientific review and an agreed delivery plan.
Explore AI & data services03 /Business & project services
Make the business decision. Deliver the work.
Choose a market, prepare a proposal, transfer project-management responsibilities or complete a scientific document.
Explore business & project servicesExplore the work
behind our services.
01 / Selected work
The work behind the words.
Explore the question, FRESCI’s contribution and the resulting work.
Clear roles. Documented outputs.
Commissioned consortium delivery
Structuring biomedical-model knowledge for the JRC
FRESCI contributed project management, vocabulary development and scientific validation to the consortium delivering the Biomedical Models Hub.
Explore the contributionPublished scientific work
Evidence synthesis for advanced non-animal models
FRESCI-affiliated experts contributed to JRC reviews, including non-animal models for immunogenicity testing of advanced therapy medicinal products.
Explore the contributionEIC-funded project · 2024–2027
Non-invasive wearable monitoring for metabolic syndrome
FRESCI contributes scientific, business, regulatory and policy intelligence to MiWear, an EIC-funded project developing a mid-infrared wearable for non-invasive biomarker monitoring.
Explore the contributionProject-management contribution
Operational support for a European research network
The HAPLO-iPS COST Action identifies Fabiana Solano of BY SCIENCE & STRATEGY as its Project Manager.
Explore the contribution02 / The assignment
A clear output.
Someone responsible
for getting there.
Your team may already have the papers, the technology, the partners or the software. The assignment is to turn those resources into a defensible recommendation, a usable system or a completed piece of work.
Discuss the work you need doneFrom available evidence to a decision.
Connect intended use, evidence, claims and limitations in a structured review—with next steps made explicit.
From fragmented information to a workflow.
Decide whether existing software, configured components or a commissioned tool best addresses the scientific task.
From a capacity gap to agreed delivery.
Transfer defined responsibilities to a named lead, with inputs, review points and acceptance criteria established.
Bring us the gap your current arrangement does not cover. You do not need to replace your whole team, advisers or systems.
03 / How we work
A clear scope.
Before work begins.
Start with the decision, task or deadline. We agree what FRESCI will deliver, what your team provides and how the result will be reviewed.
01
Define the task.
Tell us what you need to decide, build or deliver, and what is already available.
02
Agree the scope.
Confirm the outputs, inputs, responsible team, timetable, fee and acceptance criteria.
03
Deliver and review.
Work with an assigned lead. Review progress and the final output against the agreed scope.
Already have a defined brief? Proceed directly to scoping. An assessment is used where requirements or feasibility are still uncertain.
04 / The FRESCI approach
Scientific judgement.
Practical delivery.
FRESCI connects expertise in human-relevant models and regulatory science with biomedical business, project delivery and digital development.
Each engagement brings together the expertise required for its scope, including specialist delivery partners where appropriate.
Meet the people behind the workEvidence before assertion.
Sources, assumptions and uncertainty remain visible in the work.
The task determines the method.
Use the expertise and technology the assignment needs—not a compulsory package.
Responsibility is explicit.
Scope, accountable people and review arrangements are agreed before delivery.
Better evidence for human health. Our mission is to help better therapies reach people sooner by strengthening the evidence, tools and execution behind human-relevant research and development.
Explore research & tools05 / Team
Science is human.
Meet the minds behind FRESCI.
Scientific depth.
Shared direction.
We bring together biomedical science, regulatory strategy, evidence intelligence and scientific communication. Our shared focus: helping NAM and biomedical-platform teams turn complex evidence into clear decisions before scrutiny from regulators, funders and partners.
F / S&S
06 / Client testimonials
The work, in their words.
Hear directly from our clients about working with FRESCI, from scientific insight to practical project delivery.
Client testimonial
Dr. Núria Amigó
Dr. Núria Amigó shares her experience of working with FRESCI.
Watch on YouTubeClient testimonial
Professor Anna Veiga
Professor Anna Veiga and Dr. Rodríguez discuss FRESCI’s project management support for HAPLO-iPS.
Watch on YouTube07 / FRESCI on Substack
Evidence, published.
Short, decision-focused essays from FRESCI on human-relevant biomedicine, assay fit, regulatory science and evidence strategy.
↗Organoid platforms must show where their assays are fit to decide.
Organoid platforms are moving from technical excitement into a harder phase: defining the assay role, comparator, evidence threshold and uncertainty that a serious reviewer can evaluate.
No Substack posts match this search.
Published on FRESCI SubstackSubscribe and view all posts
08 / Before we start
A few useful
answers.
The right scope should make your next step clearer—not add another layer of uncertainty.
More answersIs FRESCI only for NAM companies?
No. NAMs and human biology are important areas of specialisation, while our business and project services also support wider biomedical work, including MedTech and research programmes.
Can we commission a single service?
Yes. An evidence review, market study, proposal, project-management scope, scientific document or defined tool can be commissioned independently. Additional services are included only when the task requires them.
Do we need an assessment before commissioning a tool?
Not always. A defined specification can proceed directly to scoping. An assessment is useful when the workflow, data, requirements or feasibility need further work.
Does an evidence review establish regulatory acceptance?
No. The review supports evidence planning and preparation for the agreed use. It does not itself confer regulatory acceptance or include experimental validation unless that work is separately specified.
Who will deliver the work?
The proposal identifies the accountable lead, relevant contributors and review arrangements. Technical partners, client responsibilities and continuity arrangements are made explicit where relevant.
How are fees and delivery dates determined?
They depend on the scope, required expertise, readiness of the inputs, review work and available capacity. These are agreed before delivery begins.
09 / Your next step
What does your team need to do next?
Tell us what you need to decide, build or deliver. A short description is enough to start assessing the right scope.
Send an enquiry onlineinfo@fre-sci.com
FRESCI uses your details to assess and respond to your enquiry. Privacy information
Send your project enquiry
Loading the enquiry form…